Literature DB >> 2662785

Immunity to larval Brugia malayi in BALB/c mice: protective immunity and inhibition of larval development.

D Abraham1, R B Grieve, J M Holy, B M Christensen.   

Abstract

The objective of this study was to analyze the immune response of mice to the larval stages of Brugia malayi. Male BALB/c mice were inoculated with 3 doses of irradiated third-stage larvae (L-3) of B. malayi and were subsequently challenged with L-3 implanted ip within diffusion chambers. After 3 weeks, larvae were recovered to determine their viability, length, and stage of development. A significant reduction in parasite survival was observed in immunized mice. Furthermore, larvae recovered from immunized mice were significantly shorter than larvae recovered from control mice. All larvae recovered from immunized mice were L-3, whereas 96% of larvae recovered from controls were fourth-stage larvae (L-4). Sera collected from control and immunized mice were tested for the presence of antibodies reactive with L-3 and L-4 antigens using an indirect fluorescent antibody assay employing frozen larval cross-sections as antigen. Sera recovered after challenge of control mice reacted with internal, but not surface, antigens of L-3 and L-4. Alternatively, sera from immunized mice reacted with both internal and external antigens of both L-3 and L-4.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2662785     DOI: 10.4269/ajtmh.1989.40.598

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

1.  Analysis of heavy-chain antibody responses and resistance to Parelaphostrongylus tenuis in experimentally infected alpacas.

Authors:  S R Purdy; L F Gagliardo; S Lefman; P J S Hamel; S Ku; T Mainini; G Hoyt; K Justus; L P Daley-Bauer; M S Duffy; J A Appleton
Journal:  Clin Vaccine Immunol       Date:  2012-05-16

2.  Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model.

Authors:  Sivasakthivel Thirugnanam; Pandurangan Pandiaraja; Kalyanasundaram Ramaswamy; Vadivel Murugan; Munirathinam Gnanasekar; Krithika Nandakumar; Maryada Venkata Rami Reddy; Perumal Kaliraj
Journal:  Exp Parasitol       Date:  2007-03-06       Impact factor: 2.011

Review 3.  A comprehensive, model-based review of vaccine and repeat infection trials for filariasis.

Authors:  C Paul Morris; Holly Evans; Sasha E Larsen; Edward Mitre
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

4.  Multivalent Vaccine for Lymphatic Filariasis.

Authors:  Abhilash Samykutty; Gajalakshmi Dakshinamoorthy; Ramaswamy Kalyanasundaram
Journal:  Procedia Vaccinol       Date:  2010

5.  Improving the efficacy of a prophylactic vaccine formulation against lymphatic filariasis.

Authors:  Nikhil Chauhan; Priyankana Banerjee; Vishal K Khatri; Andrew Canciamille; Jessica Gilles; Ramaswamy Kalyanasundaram
Journal:  Parasitol Res       Date:  2017-08-21       Impact factor: 2.289

6.  Multivalent fusion protein vaccine for lymphatic filariasis.

Authors:  Gajalakshmi Dakshinamoorthy; Abhilash Kumble Samykutty; Gnanasekar Munirathinam; Maryada Venkatarami Reddy; Ramaswamy Kalyanasundaram
Journal:  Vaccine       Date:  2012-10-02       Impact factor: 3.641

7.  Evaluating the efficacy of rBmHATαc as a multivalent vaccine against lymphatic filariasis in experimental animals and optimizing the adjuvant formulation.

Authors:  Gajalakshmi Dakshinamoorthy; Ramaswamy Kalyanasundaram
Journal:  Vaccine       Date:  2013-11-06       Impact factor: 3.641

8.  Novel phage display-based subtractive screening to identify vaccine candidates of Brugia malayi.

Authors:  Munirathinam Gnanasekar; Kakaturu V N Rao; Yi-Xun He; Pankaj K Mishra; Thomas B Nutman; Perumal Kaliraj; Kalyanasundaram Ramaswamy
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

9.  Protective immune responses to biolistic DNA vaccination of Brugia malayi abundant larval transcript-2.

Authors:  S K Joseph; S Sambanthamoorthy; G Dakshinamoorthy; G Munirathinam; K Ramaswamy
Journal:  Vaccine       Date:  2012-08-08       Impact factor: 3.641

10.  Host protective immunity and vaccine development studies in lymphatic filariasis.

Authors:  M V Reddy; R Alli; B C Harinath
Journal:  Indian J Clin Biochem       Date:  2000-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.